AU3885497A - Applications for regulatory region of nos isoforms - Google Patents

Applications for regulatory region of nos isoforms

Info

Publication number
AU3885497A
AU3885497A AU38854/97A AU3885497A AU3885497A AU 3885497 A AU3885497 A AU 3885497A AU 38854/97 A AU38854/97 A AU 38854/97A AU 3885497 A AU3885497 A AU 3885497A AU 3885497 A AU3885497 A AU 3885497A
Authority
AU
Australia
Prior art keywords
applications
regulatory region
nos isoforms
isoforms
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38854/97A
Inventor
John C. Salerno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JOHN C SALERNO
Original Assignee
JOHN C SALERNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JOHN C SALERNO filed Critical JOHN C SALERNO
Publication of AU3885497A publication Critical patent/AU3885497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C12N9/0075—Nitric-oxide synthase (1.14.13.39)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AU38854/97A 1996-07-12 1997-07-10 Applications for regulatory region of nos isoforms Abandoned AU3885497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/679,006 US6150500A (en) 1996-07-12 1996-07-12 Activators of endothelial nitric oxide synthase
US08679006 1996-07-12
PCT/US1997/012568 WO1998002555A1 (en) 1996-07-12 1997-07-10 Applications for regulatory region of nos isoforms

Publications (1)

Publication Number Publication Date
AU3885497A true AU3885497A (en) 1998-02-09

Family

ID=24725209

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38854/97A Abandoned AU3885497A (en) 1996-07-12 1997-07-10 Applications for regulatory region of nos isoforms

Country Status (4)

Country Link
US (2) US6150500A (en)
EP (1) EP0938567A1 (en)
AU (1) AU3885497A (en)
WO (1) WO1998002555A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE520392C2 (en) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specific peptides for the treatment of diabetes mellitus
US7175679B2 (en) * 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US6921751B1 (en) * 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
EP1141320A1 (en) * 1998-12-22 2001-10-10 The Board Of Regents, The University Of Texas System Structural basis for pterin function in nitric oxide synthase
WO2001009307A2 (en) * 1999-07-30 2001-02-08 University College London Screen for nitric oxide synthase modulators
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
GB0107563D0 (en) * 2001-03-27 2001-05-16 Amersham Pharm Biotech Uk Ltd NO synthase assay particles and method
US20030220259A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of neurological disorders
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20030224995A1 (en) * 2001-12-21 2003-12-04 Khan Nisar Ahmed Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) * 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7501391B2 (en) * 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20040013661A1 (en) * 2001-12-21 2004-01-22 Gert Wensvoort Stratification
US20030220261A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Treatment of iatrogenic disease
US20030220260A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Peptide compositions
RU2201255C1 (en) * 2001-12-26 2003-03-27 Эпштейн Олег Ильич Medicinal agent and method of regulation of vascular tonus
UA76641C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medicinal agent and method for curing diseases of prostate
UA76639C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
WO2006124820A2 (en) * 2005-05-12 2006-11-23 University Of Florida Research Foundation, Inc. Materials and methods for regulating blood flow
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US20090275795A1 (en) * 2008-05-02 2009-11-05 Zassi Medical Evolutions, Inc. Continent ostomy system with chemical neuromuscular control
EA030566B1 (en) 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Method of increasing therapeutic effectiveness of an activated-potentiated form of an antibody to an endogenous biological molecule and pharmaceutical composition
DE112011102362T5 (en) 2010-07-15 2013-04-25 Oleg Iliich Epshtein A combination pharmaceutical composition and method for treating diseases or conditions associated with neurodegenerative diseases
ITTO20110632A1 (en) 2010-07-21 2012-01-22 Oleg Iliich Epshtein METHOD TO TREAT DISORDER FROM DEFICIT ATTENTION AND HYPERACTIVITY
MX2013000804A (en) * 2010-07-21 2013-10-28 Oleg Iliich Epshtein A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders.
ES2446643R1 (en) * 2010-07-21 2015-03-06 Oleg Iliich Epshtein Combined pharmaceutical compositions and their use to prepare a drug for the treatment of vertigo, motion sickness and vegetative-vascular dystonia
USD1019804S1 (en) 2023-04-26 2024-03-26 Popsockets Llc Expandable fidget toy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268465A (en) * 1991-01-18 1993-12-07 The Johns Hopkins University Purification and molecular cloning of nitric oxide synthase
WO1993018156A1 (en) * 1992-03-05 1993-09-16 The General Hospital Corporation Endothelial nitric oxide synthase
US5498539A (en) * 1992-07-02 1996-03-12 Daiichi Pharmaceutical Co., Ltd. Bovine endothelial nitric oxide synthase nucleic acids
WO1994012645A2 (en) * 1992-11-25 1994-06-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
DE4411402A1 (en) * 1994-03-31 1995-10-05 Juergen Schrader DNA expression vectors for use in gene therapy treatment of vascular diseases

Also Published As

Publication number Publication date
US6150500A (en) 2000-11-21
US6750197B1 (en) 2004-06-15
WO1998002555A1 (en) 1998-01-22
EP0938567A1 (en) 1999-09-01

Similar Documents

Publication Publication Date Title
AU3885497A (en) Applications for regulatory region of nos isoforms
AU2438297A (en) Combinations of angiostatic compounds
AU2517397A (en) Document of value
AUPO395396A0 (en) Benzamide derivatives
AU7168696A (en) Inhibitors of regulatory pathways
AU1271297A (en) Inhibitor of ceramidase
AU2243497A (en) Laser induced improvement of surfaces
AU5161998A (en) Quadrapod safety support
AU3549397A (en) Over-expression of proteins
AU3107795A (en) Inhibitors of the benzamidine type
AU2907697A (en) Decontamination of metal
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU5136598A (en) Plaster containing felbinac
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU6143998A (en) Regulators of apoptosis
AU3123697A (en) Angiostatic compounds
AU2557097A (en) Enhanced expression of transgenes
AU2728395A (en) Dog-food dressing
AUPO071296A0 (en) Heating of components
AU2728295A (en) Cat-food dressing
AU5126298A (en) Inhibition of crib-biting
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AUPO950097A0 (en) Hvdr isoforms
AU2595297A (en) Use of aminoalkylcarboxylic derivatives
AU3934395A (en) Enzyme stabilization